The incidence rate of melanoma is dramatically increasing worldwide, raising it to the fifth
most common cancer in men and the sixth in women currently. Resistance generally occurs …

Melanoma is one of the most severe cancerous diseases. The cells employ multiple
signaling pathways, such as ERK, HGF/c-MET, WNT, and COX-2 to cause the cell …

As cutaneous melanoma is a highly aggressive and drug-resistant cancer, there is intense
research focusing on developing new, efficient drugs. Nanomedicine focuses on developing …

Background: Nanotechnology deals with the manufacturing of materials at the atomic and
molecular scale. According to the National Nanotechnology Initiative, nanotechnology …

Melanoma is a progressive disease that claims many lives each year due to lack of
therapeutics effective for the long‐term treatment of patients. Currently, the best treatment …

The past decade has witnessed a breakthrough in novel strategies to treat cancer. One of
the most common cancer treatment modalities is chemotherapy which involves …

Melanoma (MEL) is a less common type of skin cancer, but it is more aggressive with a high
mortality rate. The World Cancer Research Fund International (GLOBOCAN 2012) estimates …

Cancer is a progressive disease of multi-factorial origin that has risen worldwide, probably
due to changes in lifestyle, food intake, and environmental changes as some of the reasons …

Background: Cancer of the skin is one of the most frequent kinds of cancer around the globe
and has substantial consequences for both public health and the economy. Co-delivery of …

Skin-cancer is the commonest malignancy affecting huge proportion of the population,
reaching heights in terms of morbidity. The treatment strategies are presently focusing on …